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INTRODUCTION 
Bladder cancer is ninth in terms of global outbreak. More 
than 12 million new cases occur worldwide every year, 
with about 145,000 deaths reported due to its.1 
Bladder cancer was more prevalent in developed 
countries but currently the incidence of death due to 
bladder cancer has decreasing trend in these countries but 
increasing trend in developing countries.2-4 
Study registered data of cancer in Iran in years 2003-
2009 showed that 27898 cases of bladder cancer was 
registered in the country of Iran that of them 2745 cases 
were in 2003 which was increased to 4601 cases in 2009. 
In country provinces the most incidences was seen in 
Men in Tehran and the least in South Khorasan and for 
female the most was seen in South Khorasan and the least 
in Kohkoloyeh Boyer-Ahmad. In Ardabil, the 
standardized incidence rate was 9.92 per 100000 in men 
and 3.22 per 100000 in women.5 
ABSTRACT 
 
Background: Bladder cancer is the most common cancer of the urethra and genital tract and is ranked ninth in terms 
of its incidence. The aim of this study was to investigate the clinical and laboratory characteristics of patients with 
bladder cancer in Ardabil province.  
Methods: This is a cross-sectional study that has been done on 81 patients with bladder cancer. Necessary 
information such as age, sex, blood type, RH, family history of bladder cancer, smoking, drug use, tumor stage and 
grade and type of tumor were collected from the patient's hospital record or by telephone interview.  
Results: Sixty seven patients (82.7%) were male. The mean age of patients was 66.9±15.02 years. The blood group 
A, was the most common type of blood. (39.5%) of all patients, 54.3% had cigarette smoking and 47(58%) live in 
city. The most common type of tumor grade was high-grade papillary urethral carcinoma (48.1%).The most common 
stages of the tumor was Ta (40.7%) and the most common clinical manifestation was hematuria (90.1%). 27 patients 
(33.3%) had a delay of more than 3 months between observation of hematuria and cystoscopy.  
Conclusions: The findings showed that the most common grade and stage of the tumor in patients were high-grade 
papillary urethral carcinoma and Ta; the most prevalent clinical presentation was hematuria; the prevalence of the 
disease was higher among males, at ages older than 70 years old, in people with a blood type A, and among people 
living in urban areas; a study with bigger sample size should be done in future in the country Iran.  
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The golden standard in diagnosis and staging of bladder 
cancer, was systescopia in which all bladder cancer cases 
have been observed and studied and all of observed 
tumors evaluated in terms of size, location and form of 
growth (papillary or smooth or solid). Treatment of 
bladder tumors given the severity of the disease and the 
involved layers, is different from scarring to cancerous 
cystsectomy. Current studies about incidence, clinical and 
laboratory characteristics of patients with bladder cancer 
in various areas showed that this disease has relation with 
culture, behavior and life style of people.6,7 
Bladder cancer is a cancer with high mortality rate, and 
any action that can somehow help in early diagnosis of it, 
can reduce the cost of treatment and increase the 
possibility of responding to treatment and the rate of 
recovery in patients. Studies showed that Hematuria is 
the most common clinical manifestation of bladder 
cancer which has seen in 75% of patients and also, 
bladder stimulus symptoms such as urticaria or urinalysis 
may be a primary manifestation of disease.8,9 
The prevalence of disease in male was 4 to 5.2 times 
more than female and the mean onset age of patients was 
65 to 70 years.10,11 
The prevalence of this disease is related to smoking and 
exposure to potential carcinogens.12-16 
Pathologic studies in patients with bladder cancer have 
shown that, generally, orthelial or transdermal 
cardiomyocytes are the most common histological 
findings of this cancer.17 
The aim of this study was to investigate the clinical and 
laboratory characteristics of patients with bladder cancer 
in Ardabil province in 2016-2017. 
METHODS 
In this cross-sectional study 81 patients with bladder 
cancer in Ardabil city during April 2016 to September 
2017. Patients who had symptoms such as Hematuria, 
diarrhea, frequent urination and in the ultrasonography of 
the bladder they have mass and candidate for cystoscopy 
and resection of the tumor, were entered the study and 
Patients with incomplete hospital records excluded from 
the study. 
After sending samples to the laboratory, the report of 
pathology studied in terms of tumor grade and stage. 
Necessary information such as age, sex, blood type, RH, 
family history of bladder cancer, smoking and opium use, 
stage and degree of tumor, distance from first hematuria 
until referred to systescopia and type of tumor collected 
from patients files and or collected by call and interview 
with patient and their families. Collected data analyzed 
by statistical methods in SPSS 19. 
RESULTS 
Of all patients, 67 (82.7%) were male and rest of them 
were female. The mean age of patients was 66.9±15.02 
and most of them were in age group 70-90 years (49.4%). 
Of all patients, 32 (39.5%) have blood type A and 71 
(87.7%) have positive RH (Table 1). 
Table 1: The demographic data of patients. 
% n Variables 
87.7 71 RH+ 
17.3 14 Female  
Sex 
82.7 67 Male  
66.6 54 Smoking and hookah 
14.8 12 Opium  
58 47 Urban  Residence 
place 42 34 Rural  
39.5 32 A 
Blood type 
18.6 15 B 
4.9 4 AB 
37 30 O 
2.4 2 <30 
Age groups  48.2 39 30-70 
49.4 40 70-90 
2.5 2 Family history + 
The highest grade of bladder tumor was in patients with 
high-grade papillary urethral carcinoma with 39 (48.1%) 
(Figure 1). 
 
Figure 1: The grade of bladder cancer in patients. 
The stage of tumor in most of patients was in stage Ta 
with 33 (40.7%) (Figure 2). 
The type of tumor in most of patients was papillary with 
67.9% (Figure 3). 
The first symptoms in most of patients was Hematuria 
with 90.1% (Figure 4). 
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Low grade papillary urothelial carcinoma
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The mean of distance time between observation 
hematuria and referred to systescopia in patients was 
2.85±2.83 month that most of patients have delay in this 
process (33.3%). 
 
Figure 2: The stage of bladder tumor in patients. 
 
Figure 3: The type of tumor in patients. 
 
Figure 4: The symptoms in patients.  
DISCUSSION 
In this study, the frequency of bladder cancer in male 
with 82.7% was more than female with 17.3% and sex 
ratio male to female was 4.8 to 1. In other studies in Iran 
and other places, the rate of cancer in male was more and 
the sex ratio was different from 3-8.6 to 1.5,18-28 
In this study, the mean age of patients was 66.9±15.02 
and similar to other studies there wasn’t significant 
difference between two sexes.7,26-29,30-34 
More than 90% of patients in this study have age up 50 
years that in a study in Iran during 2003-2009, the most 
of incidence was seen in age group up 80 which in line 
with our study result.5 
Also, in a study in Sri Lanka 89.9% of patients have age 
up 50 years and in Fedva et al study, in Egypt most of 
patients were in age group 60-69 years.2 
The pattern of cancer incidence is related to regional 
conditions and physical-chemical environmental factors, 
nutritional habits, and genetic factors that can justify 
differences in various studies. The most grade of tumor in 
patients was high grade papillary urothelial carcinoma 
which was seen in 39 (48.1%) of patients. Our study 
results was similar to Sjöström and et al in Sweden, 
Ramazani et al study, Payandeh and et al study in 
Kermanshah and Dobbs and et al study in 
America.18,23,24,29 But in some studies the most of grade 
was low-degree tumors which can pointed to the 
Sasikumar et al in Sri Lanka, Biswas et al study in India 
and Salehi study in Shiraz.19,30 The most frequent stage of 
bladder tumors in our study was Ta, which was seen in 
40.7% of all patients. In Sjöström et al study in Sweden, 
Dobbs and et al study in America and Gupta and et al 
study in India the most frequent stage was Ta and then 
T1, T2 which was in line with our study results.18,29 The 
most symptoms in patients was hematuria with 90.1% 
and in other studies similar to our study results the most 
prevalent symptoms was hematuria.7,21,23,26,28 
According to the current and other study results it can be 
said that the most important clinical manifestation of 
bladder cancer is hematuria and it need for more attention 
from physicians to urinary symptoms, especially 
hematuria, as a possible sign of cancer. The mean of 
distance time between observation hematuria and referred 
to systescopia in patients was 2.85±2.83 month that most 
of patients have delay in this process (33.3%). The mean 
of delay in a study in Esfahan was 2.76 month which was 
similar to our study results. In generally studies showed 
that the distance more than 3 month from onset to 
treatment significantly decreases the rate of treatment 
response and this suggests the need for early diagnosis of 
bladder cancer.32 
In our study 54.3% of patients have history of smoking 
which was similar to other studies.2,20,23-26 
In generally, the most important risk factor for bladder 
cancer was smoking which increase the risk of cancer 
about 4 times and it was estimated that smoking is causes 
of 50% of all bladder cancer cases in male and 30% in 
female.5,32,33 
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In our study, most of patients with 39.5% have blood type 
A which was upper than country rate with 31.63%.5 In 
Shafeei et al study in Babol, two blood groups A and O 
have the most frequency.7 In Biswas et al study in India, 
most of patients was in Blood group B with 41%. In this 
study most of patients live in urban areas with 58%. 
Contrary to the current study, in Ramazani et al study, in 
Kermanshah 75% live in Rural but in Ahmadi et al study 
in Mazandaran most of patients about 60.7% live in 
Urban.23,26 In a study in Egypt this rate was similar 
between Urban and Rural.2 
Physical-chemical environmental contact with harmful 
substances is one of the known risk factors for bladder 
cancer and it was reported that bladder cancer is prevalent 
in industrial areas.35 
It is thought that, the increasing of the disease in urban 
areas relates to rural areas which are partly due to the 
industrialization of cities towards the countryside; the 
results of the present study also confirm these findings. 
Of course, there are a number of environmental and 
geographical risk factors that are common in rural areas 
such as agricultural waste and heavy metals entering 
underground waters and suffer these areas with problems 
in futre.36 
CONCLUSION  
The findings of this study showed that the most common 
grade and stage of tumor in patients with bladder cancer 
were high-grade papillary urethral carcinoma and Ta, the 
most common pre-clinical presentation was hematuria. 
The prevalence of this disease was higher among men 
over the age of 70 years, in people with type A, and 
among people living in urban areas. Also, cigarette 
smoking was common among these patients, and one-
third of patients between hematuria and cystoscopy were 
delayed for more than 3 months. A study with a higher 
sample size is necessary in the future to achieve more 
accurate results. 
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